Kenya
The Kenyan Government will soon rolled out a drug that will be taken by HIV negative people who are mostly at risk of HIV infection.
The drug, known as Pre-exposure Prophylaxis will be administered daily by those at high risk of contracting the virus before being made accessible to the rest of the Kenyan population.
The drug coats human being’s cells and prevents the HIV virus from attaching to the cells, thus being able to fight off the HIV virus.

This came after a study conducted both in Kenya and Uganda showed that if taken once daily, the drug can prevent HIV infection by more than one percent.
If used consistently, the drug can significantly reduce the risk of getting HIV from unprotected sex.
Kenya is the second country after South Africa to roll out the program said to reduce the risk of HIV infection in people who are at high risk by up to 92 per cent if taken consistently.
01:11
South Africa gives twice-yearly HIV prevention jab the green light
Go to video
South Africa's health minister hails planned rollout of new HIV prevention jab
01:16
HIV prevention injection slashed from $28,000 to $40
01:37
UN warns millions will die by 2029 if new funding for HIV programs isn't found
02:01
Eswatini fears decades of progress in fight against HIV could be undone by US funding cuts
01:29
US medication safety agency approves biannual preventive HIV shot